Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

NCT ID	NCT04338685
Title	A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Hoffmann-La Roche
Indications	skin melanoma Advanced Solid Tumor hepatocellular carcinoma pancreatic ductal adenocarcinoma biliary tract cancer gallbladder cancer renal cell carcinoma triple-receptor negative breast cancer fibrolamellar carcinoma ocular melanoma colorectal cancer stomach cancer
Therapies	RO7119929 + Tocilizumab
Age Groups:	senior \| adult
Covered Countries	USA \| ESP